Works matching DE "FIBROBLAST growth factor receptors"

Results: 1314

Intrafamilial Phenotypic Variability of the FGFR1 p.Cys277Tyr Variant: A Case Report and Review of the Literature.

Published in:

Genes, 2025, v. 16, n. 5, p. 495, doi. 10.3390/genes16050495

By:

Szoszkiewicz, Anna;
Sowińska-Seidler, Anna;
Gruca-Stryjak, Karolina;
Jamsheer, Aleksander

Publication type:

Article

Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor.

Published in:

Cell Communication & Signaling, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12964-025-02269-x

By:

Ciura, Krzysztof;
Sobota, Olimpia;
Chorążewska, Aleksandra;
Krowarsch, Daniel;
Porębska, Natalia;
Opaliński, Łukasz

Publication type:

Article

Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor.

Published in:

Cell Communication & Signaling, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12964-025-02269-x

By:

Ciura, Krzysztof;
Sobota, Olimpia;
Chorążewska, Aleksandra;
Krowarsch, Daniel;
Porębska, Natalia;
Opaliński, Łukasz

Publication type:

Article

RBFOX and SUP-12 sandwich a G base to cooperatively regulate tissue-specific splicing.

Published in:

Nature Structural & Molecular Biology, 2014, v. 21, n. 9, p. 778, doi. 10.1038/nsmb.2870

By:

Kuwasako, Kanako;
Takahashi, Mari;
Unzai, Satoru;
Tsuda, Kengo;
Yoshikawa, Seiko;
He, Fahu;
Kobayashi, Naohiro;
Güntert, Peter;
Shirouzu, Mikako;
Ito, Takuhiro;
Tanaka, Akiko;
Yokoyama, Shigeyuki;
Hagiwara, Masatoshi;
Kuroyanagi, Hidehito;
Muto, Yutaka

Publication type:

Article

Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion.

Published in:

Nature Structural & Molecular Biology, 2014, v. 21, n. 2, p. 180, doi. 10.1038/nsmb.2752

By:

Timsah, Zahra;
Ahmed, Zamal;
Lin, Chi-Chuan;
Melo, Fernando A;
Stagg, Loren J;
Leonard, Paul G;
Jeyabal, Prince;
Berrout, Jonathan;
O'Neil, Roger G;
Bogdanov, Mikhail;
Ladbury, John E

Publication type:

Article

FGFR3 gene mutations screening in non-muscle invasive bladder cancer (NMIBC) in the Tunisian population.

Published in:

Molecular Biology Reports, 2025, v. 52, n. 1, p. 1, doi. 10.1007/s11033-025-10441-2

By:

Saidani, Bilel;
Boubaker, Nouha Setti;
Chakroun, Marouen;
Ayed, Haroun;
Ksontini, Meriem;
Naimi, Zeineb;
Meddeb, Khedija;
Saadi, Ahmed;
Rammeh, Soumaya;
Slama, Mohamed Riadh Ben

Publication type:

Article

A novel Fibroblast Growth Factor Receptor family member promotes neuronal outgrowth and synaptic plasticity in Aplysia.

Published in:

Amino Acids, 2014, v. 46, n. 11, p. 2477, doi. 10.1007/s00726-014-1803-2

By:

Pollak, Daniela;
Minh, Bui;
Cicvaric, Ana;
Monje, Francisco

Publication type:

Article

Upregulation of Fibroblast Growth Factor 19 Is Associated with the Initiation of Colorectal Adenoma.

Published in:

Digestive Diseases, 2019, v. 37, n. 3, p. 214, doi. 10.1159/000494454

By:

Wang, Dongyang;
Zhang, Jianjun;
Li, Zengjun;
Han, Jianjun;
Gao, Yongsheng;
Chen, Ming;
Li, Yanqing

Publication type:

Article

The molecular mechanism of gemcitabine in inhibiting the HIF-1α/VEGFB/FGF2/FGFR1 signaling pathway for ovarian cancer treatment.

Published in:

Discover Oncology, 2025, v. 16, n. 1, p. 1, doi. 10.1007/s12672-024-01723-5

By:

Wang, Liangliang;
Ma, Shanshan;
Su, Huiwen;
Nie, Dandan;
Wang, Lihua

Publication type:

Article

The roles of FGFR3 and c-MYC in urothelial bladder cancer.

Published in:

Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01173-z

By:

Bogale, Dereje E.

Publication type:

Article

The Effect of Yinchenhao Decoction on the Pharmacokinetic Profile of Futibatinib by HPLC-MS/MS.

Published in:

Separations (2297-8739), 2024, v. 11, n. 7, p. 213, doi. 10.3390/separations11070213

By:

Wang, Chunfu;
Liang, Songmao;
Xu, Jiachen;
Zhai, Yingfan;
Chen, Jianghui;
Qiu, Xiangjun

Publication type:

Article

FGFR2-fusions define a clinically actionable molecular subset of pancreatic cancer.

Published in:

NPJ Precision Oncology, 2024, v. 8, n. 1, p. 1, doi. 10.1038/s41698-024-00683-x

By:

Stein, Leah;
Murugesan, Karthikeyan;
Reeser, Julie W.;
Risch, Zachary;
Wing, Michele R.;
Paruchuri, Anoosha;
Samorodnitsky, Eric;
Hoskins, Emily L.;
Dao, Thuy;
Smith, Amy;
Le, Dat;
Babcook, Melissa A.;
Chang, Yi Seok;
Avenarius, Matthew R.;
Imam, Muhammad;
Freud, Aharon G.;
Roychowdhury, Sameek

Publication type:

Article

Spatial profiling of cancer-associated fibroblasts of sporadic early onset colon cancer microenvironment.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00474-w

By:

Furuhashi, Satoru;
Bustos, Matias A.;
Mizuno, Shodai;
Ryu, Suyeon;
Naeini, Yalda;
Bilchik, Anton J.;
Hoon, Dave S. B.

Publication type:

Article

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00462-0

By:

Furugaki, Koh;
Fujimura, Takaaki;
Mizuta, Hayato;
Yoshimoto, Takuya;
Asakawa, Takashi;
Yoshimura, Yasushi;
Yoshiura, Shigeki

Publication type:

Article

SOMATIC MUTATIONS IDENTIFICATION OF FGFR3 AMONG HCC EGYPTIAN PATIENTS USING NGS.

Published in:

Egyptian Journal of Genetics & Cytology, 2022, v. 51, n. 2, p. 103

By:

ELFEKY, AHMED M.;
ElSHAARAWY, A. A.;
EBIED, M. E.;
ELHAMSHARY, MANAL O.;
TALAAT, RANDA M.;
SAKR, M. A.;
KHALIFA, M. K.;
AHMED, E. A.;
NASR, GHADA M.

Publication type:

Article

Defective FGFR1 Signaling Disrupts Glucose Regulation: Evidence From Humans With FGFR1 Mutations.

Published in:

Journal of the Endocrine Society, 2024, v. 8, n. 8, p. 1, doi. 10.1210/jendso/bvae118

By:

Stamou, Maria I;
Chiu, Crystal J;
Jadhav, Shreya V;
Lopes, Vanessa Ferreira;
Salnikov, Kathryn B;
Plummer, Lacey;
Lippincott, Margaret F;
Lee, Hang;
Seminara, Stephanie B;
Balasubramanian, Ravikumar

Publication type:

Article

Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.

Published in:

JNCI Cancer Spectrum, 2024, v. 8, n. 3, p. 1, doi. 10.1093/jncics/pkae030

By:

Necchi, Andrea;
Ramlau, Rodryg;
González, Alejandro Falcón;
Chaudhry, Arvind;
Todenhöfer, Tilman;
Tahbaz, Rana;
Fontana, Elisa;
Giannatempo, Patrizia;
Deville, Jean-Laurent;
Pouessel, Damien;
Yoon, Shinkyo;
Powles, Thomas;
Bernat, Mathieu;
Häckl, Manuel;
Marszewska, Michalina;
McKernan, Phil;
Saulay, Mikael;
Scaleia, Federica;
Engelhardt, Marc;
Loriot, Yohann

Publication type:

Article

基于肠 FXR‐FGF15 通路探讨沙棘熊果酸对酒精性肝损伤小鼠的影响.

Published in:

Food Research & Development, 2025, v. 46, n. 2, p. 9, doi. 10.12161/j.issn.1005‐6521.2025.02.002

By:

李楠;
赵雪;
郭少龙;
张文龙;
戈娜;
李智;
林琰

Publication type:

Article

Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 972, doi. 10.3390/jcm8070972

By:

Rosso, Valentina;
Panuzzo, Cristina;
Petiti, Jessica;
Carturan, Sonia;
Dragani, Matteo;
Andreani, Giacomo;
Fava, Carmen;
Saglio, Giuseppe;
Bracco, Enrico;
Cilloni, Daniela

Publication type:

Article

Reduced Expression of Sprouty1 Contributes to the Aberrant Proliferation and Impaired Apoptosis of Acute Myeloid Leukemia Cells.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 972, doi. 10.3390/jcm8070972

By:

Rosso, Valentina;
Panuzzo, Cristina;
Petiti, Jessica;
Carturan, Sonia;
Dragani, Matteo;
Andreani, Giacomo;
Fava, Carmen;
Saglio, Giuseppe;
Bracco, Enrico;
Cilloni, Daniela

Publication type:

Article

Fibroblast Growth Factor Family in the Progression of Prostate Cancer.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 2, p. 183, doi. 10.3390/jcm8020183

By:

Teishima, Jun;
Hayashi, Tetsutaro;
Nagamatsu, Hirotaka;
Shoji, Koichi;
Shikuma, Hiroyuki;
Yamanaka, Ryoken;
Sekino, Yohei;
Goto, Keisuke;
Inoue, Shogo;
Matsubara, Akio

Publication type:

Article

Targeting Cellular Trafficking of Fibroblast Growth Factor Receptors as a Strategy for Selective Cancer Treatment.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 1, p. 7, doi. 10.3390/jcm8010007

By:

Porębska, Natalia;
Latko, Marta;
Kucińska, Marika;
Zakrzewska, Małgorzata;
Otlewski, Jacek;
Opaliński, Łukasz

Publication type:

Article

Design, synthesis and biological evaluation of novel 2-hydroxy-1H-indene-1,3(2H)-dione derivatives as FGFR1 inhibitors.

Published in:

Pharmacia (0428-0296), 2024, v. 71, n. 1, p. 1, doi. 10.3897/pharmacia.71.e122127

By:

Al-Mahadeen, Mohammed M.;
Jaber, Areej M.;
Al-Najjar, Belal O.

Publication type:

Article

The effect of fibroblast growth factor receptor inhibition on resistance exercise training-induced adaptation of bone and muscle quality in mice.

Published in:

Korean Journal of Physiology & Pharmacology, 2022, v. 26, n. 3, p. 207, doi. 10.4196/kjpp.2022.26.3.207

By:

Suhan Cho;
Hojun Lee;
Ho-Young Lee;
Sung Joon Kim;
Wook Song

Publication type:

Article

Zerumbone, Sesquiterpene Photochemical from Ginger, Inhibits Angiogenesis.

Published in:

Korean Journal of Physiology & Pharmacology, 2015, v. 19, n. 4, p. 335, doi. 10.4196/kjpp.2015.19.4.335

By:

Ju-Hyung Park;
Geun Mook Park;
Jin-Kyung Kim

Publication type:

Article

Molecular Analysis of Twist1 and FGF Receptors in a Rabbit Model of Craniosynostosis: Likely Exclusion as the Loci of Origin.

Published in:

International Journal of Genomics, 2013, p. 1, doi. 10.1155/2013/305971

By:

Gallo, Phillip H.;
Cray Jr., James J.;
Durham, Emily L.;
Mooney, Mark P.;
Cooper, Gregory M.;
Kathju, Sandeep

Publication type:

Article

Single‑agent nintedanib suppresses metastatic osteosarcoma growth by inhibiting tumor vascular formation.

Published in:

Oncology Letters, 2024, v. 27, n. 3, p. N.PAG, doi. 10.3892/ol.2024.14254

By:

Shimizu, Takatsune;
Sagara, Atsunobu;
Fukuchi, Yumi;
Muto, Akihiro

Publication type:

Article

CD155 immunohistochemical expression in upper tract urothelial carcinoma predicts poor prognosis.

Published in:

Oncology Letters, 2022, v. 24, n. 5, p. N.PAG, doi. 10.3892/ol.2022.13534

By:

Ikeda, Junichi;
Ohe, Chisato;
Yoshida, Takashi;
Saito, Ryoichi;
Tsuta, Koji;
Kinoshita, Hidefumi

Publication type:

Article

Cancer-associated gene analysis of cervical cytology samples and liquid-based cytology significantly improve endometrial cancer diagnosis sensitivity.

Published in:

Oncology Letters, 2022, v. 24, n. 4, p. N.PAG, doi. 10.3892/ol.2022.13496

By:

Nimura, Ryo;
Kondo, Eiji;
Yoshida, Kenta;
Kubo-Kaneda, Michiko;
Nii, Masafumi;
Ikeijiri, Makoto;
Nakamura, Maki;
Imai, Hiroshi;
Okugawa, Yoshinaga;
Nakatani, Kaname;
Ikeda, Tomoaki

Publication type:

Article

PTCH1 mutant small cell glioblastoma in a patient with Gorlin syndrome: A case report.

Published in:

Oncology Letters, 2022, v. 24, n. 3, p. N.PAG, doi. 10.3892/ol.2022.13446

By:

Dorsey, John T.;
Mott, Ryan T.;
Lack, Christopher M.;
Britt, Nicholas;
Ramkissoon, Shakti H.;
Morris, Bonny B.;
Carter, Annette;
Detroye, Alisha T.;
Chan, Michael;
Tatter, Stephen;
Lesser, Glenn J.

Publication type:

Article

Identification of the potential roles of ring finger protein 8 in TP53-mutant breast cancer.

Published in:

Oncology Letters, 2021, v. 21, n. 1, p. N.PAG

By:

Zhao, Feng;
Wang, Peibin;
Guo, Yan;
Lu, Qi;
Kong, Xu;
Su, Dongwei;
Li, Hengyu;
Liu, Guoping;
Liu, Chaoqian

Publication type:

Article

Therapeutic implications of fibroblast growth factor receptor inhibitors in a combination regimen for solid tumors.

Published in:

Oncology Letters, 2020, v. 20, n. 3, p. 2525, doi. 10.3892/ol.2020.11858

By:

Luo, Hong;
Zhang, Tao;
Cheng, Peng;
Li, Dong;
Ogorodniitchouk, Oleksandr;
Lahmamssi, Chaimaa;
Wang, Ge;
Lan, Meiling

Publication type:

Article

In vitro antitumor effects of FGFR and PI3K inhibitors on human papillomavirus positive and negative tonsillar and base of tongue cancer cell lines.

Published in:

Oncology Letters, 2019, v. 18, n. 6, p. 6249, doi. 10.3892/ol.2019.10973

By:

Holzhauser, Stefan;
Kostopoulou, Ourania N.;
Ohmayer, Anna;
Lange, Birthe K.A.;
Ramqvist, Torbjörn;
Andonova, Teodora;
Bersani, Cinzia;
Wickström, Malin;
Dalianis, Tina

Publication type:

Article

Receptor tyrosine kinase expression in high-grade gliomas before and after chemoradiotherapy.

Published in:

Oncology Letters, 2019, v. 18, n. 6, p. 6509, doi. 10.3892/ol.2019.11017

By:

Wang, Kuanyu;
Huang, Ruoyu;
Wu, Chenxing;
Li, Guanzhang;
Zhao, Zheng;
Hu, Huimin;
Liu, Yanwei

Publication type:

Article

A potential novel therapy for FGFR1-amplified pancreatic cancer with bone metastasis, screened by next-generation sequencing and a patient-derived xenograft model.

Published in:

Oncology Letters, 2019, v. 17, n. 2, p. 2303

By:

Guan, Zhonghai;
Lan, Huanrong;
Sun, Dan;
Wang, Xuanwei;
Jin, Ketao

Publication type:

Article

FGFR1 and HER1 or HER2 co‑amplification in breast cancer indicate poor prognosis.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 8206, doi. 10.3892/ol.2018.8423

By:

ChEN, Shinan;
Qiu, Yan;
Guo, PENg;
Pu, Tianjie;
FENg, Ye;
Bu, Hong

Publication type:

Article

Prognostic relevance of FGFR2 expression in stage II/III gastric cancer with curative resection and S-1 chemotherapy.

Published in:

Oncology Letters, 2018, v. 15, n. 2, p. 1853, doi. 10.3892/ol.2017.7515

By:

Hosoda, Kei;
Yamashita, Keishi;
Ushiku, Hideki;
Ema, Akira;
Moriya, Hiromitsu;
Mieno, Hiroaki;
Washio, Marie;
Watanabe, Masahiko

Publication type:

Article

Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status.

Published in:

Oncology Letters, 2017, v. 14, n. 3, p. 3817, doi. 10.3892/ol.2017.6621

By:

Ho Won Kang;
Ye-Hwan Kim;
Pildu Jeong;
Cheol Park;
Won Tae Kim;
Dong Hee Ryu;
Eun-Jong Cha;
Yun-Sok Ha;
Tae-Hwan Kim;
Tae Gyun Kwon;
Sung-Kwon Moon;
Yung Hyun Choi;
Seok-Joong Yun;
Wun-Jae Kim

Publication type:

Article

Molecular heterogeneity in the novel fusion gene APIP-FGFR2: Diversity of genomic breakpoints in gastric cancer with high-level amplifications at 11p13 and 10q26.

Published in:

Oncology Letters, 2017, v. 13, n. 1, p. 215, doi. 10.3892/ol.2016.5386

By:

TAKASHI OKUDA;
TOMOHIKO TAKI;
KAZUHIRO NISHIDA;
YOSHIAKI CHINEN;
HISAO NAGOSHI;
CHOUHEI SAKAKURA;
MASAFUMI TANIWAKI

Publication type:

Article

Receptor FGFRL1 acts as a tumor suppressor in nude mice when overexpressed in HEK 293 Tet-On cells.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4524, doi. 10.3892/ol.2016.5245

By:

LEI ZHUANG;
STEINBERG, FLORIAN;
TRUEB, BEAT

Publication type:

Article

FGFR3 silencing by siRNA inhibits invasion of A549 cells.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 4319, doi. 10.3892/ol.2016.5278

By:

YUHUA LI;
XIGUANG LIU;
HONGJUN ZHANG;
TAO JIANG;
WENJING XIAO;
SHUFEN ZHAO;
XIAOYUN YU;
FANJIE HAN

Publication type:

Article

miR-494 inhibits ovarian cancer cell proliferation and promotes apoptosis by targeting FGFR2.

Published in:

Oncology Letters, 2016, v. 11, n. 6, p. 4245, doi. 10.3892/ol.2016.4527

By:

XIAOJUAN ZHAO;
YUN ZHOU;
YU CHEN;
FENG YU

Publication type:

Article

Chronic myelogenous leukemia-like hematological malignancy with t(8;22) in a 26-year-old pregnant woman: A case report.

Published in:

2016

By:

YOU‑WEN QIN;
YI‑NING YANG;
PING BAI;
CHUN WANG

Publication type:

Case Study

Targeted Therapies in Advanced Cholangiocarcinoma.

Published in:

Life (2075-1729), 2023, v. 13, n. 10, p. 2066, doi. 10.3390/life13102066

By:

Storandt, Michael H.;
Kurniali, Peter C.;
Mahipal, Amit;
Jin, Zhaohui

Publication type:

Article

Loss of FGFR3 Delays Acute Myeloid Leukemogenesis by Programming Weakly Pathogenic CD117-Positive Leukemia Stem-Like Cells.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.632809

By:

Guo, Chen;
Ran, Qiuju;
Sun, Chun;
Zhou, Tingting;
Yang, Xi;
Zhang, Jizhou;
Pang, Shifeng;
Xiao, Yechen

Publication type:

Article

The Role of Fibroblast Growth Factor 10 Signaling in Duodenal Atresia.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00250

By:

Jones, Matthew L. M.;
Sarila, Gulcan;
Chapuis, Pierre;
Hutson, John M.;
King, Sebastian K.;
Teague, Warwick J.

Publication type:

Article

Temporospatial Expression of Fgfr1 and 2 During Lung Development, Homeostasis, and Regeneration.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00120

By:

Yuan, Tingting;
Klinkhammer, Kylie;
Lyu, Handeng;
Gao, Shan;
Yuan, Jie;
Hopkins, Seantel;
Zhang, Jin-San;
De Langhe, Stijn P.

Publication type:

Article

FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00154

By:

Wang, Xue;
Zhu, Liyun;
Hu, Jian;
Guo, Ruili;
Ye, Shasha;
Liu, Fei;
Wang, Dongxue;
Zhao, Yeli;
Hu, Aiping;
Wang, Xiaojie;
Guo, Kaiming;
Lin, Li

Publication type:

Article

Multiple receptor tyrosine kinases regulate dengue infection of hepatocytes.

Published in:

Frontiers in Cellular & Infection Microbiology, 2024, p. 1, doi. 10.3389/fcimb.2024.1264525

By:

Bourgeois, Natasha M.;
Ling Wei;
Ho, Nhi N. T.;
Neal, Maxwell L.;
Seferos, Denali;
Tongogara, Tinotenda;
Mast, Fred D.;
Aitchison, John D.;
Kaushansky, Alexis

Publication type:

Article

Correction.

Published in:: 2021
Publication type:: corrected article